Related Experiment Video
Updated: Feb 15, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Rhinovirus in Febrile Infants and Risk of Bacterial Infection
Anne J Blaschke1, E Kent Korgenski2,3, Jacob Wilkes3
1Departments of Pediatrics, anne.blaschke@hsc.utah.edu.
Insights
Human rhinovirus (HRV) in febrile infants does not increase urinary tract infection risk. HRV detection may indicate a lower risk of invasive bacterial infection in infants aged 29-90 days.
Area of Science:
- Pediatrics
- Infectious Diseases
- Virology
Background:
- Febrile infants with viral infections generally have a lower risk of bacterial infections.
- The specific risk of bacterial infection in infants with human rhinovirus (HRV) has not been well-established.
Purpose of the Study:
- To investigate the association between HRV detection and the risk of bacterial infection in febrile infants.
- To determine if HRV influences the risk of urinary tract infections (UTIs) or invasive bacterial infections (IBIs) in infants.
Main Methods:
- A retrospective study identified febrile infants (1-90 days old) who underwent respiratory viral PCR testing.
- Relative risk (RR) of bacterial infection was calculated for infants with HRV, other viruses, or no virus detected.
- Data were collected from 22 hospitals between 2007 and 2016.
Main Results:
- Of 10,964 infants, 4,037 had viral testing, with 2,212 positive for a virus, including 1,392 for HRV.
- Bacterial infections occurred in 9.5% of infants; HRV-positive infants had a higher risk of bacterial infection (7.8% vs 3.7%) compared to non-HRV virus-positive infants.
- HRV detection did not significantly alter UTI risk at any age or IBI risk in infants 1-28 days old, but was associated with decreased IBI risk in infants 29-90 days old (RR 0.52).
Conclusions:
- Human rhinovirus is a common finding in febrile infants.
- HRV detection does not increase the risk of UTIs or IBIs in young infants (1-28 days).
- HRV may be a relevant factor when assessing IBI risk in infants aged 29-90 days.
Background:
Febrile infants with viral respiratory infections have a reduced risk of bacterial infection compared with virus-negative infants. The risk of concomitant bacterial infection in febrile infants positive for human rhinovirus (HRV) by polymerase chain reaction (PCR) is unknown.
Methods:
Infants 1-90 days old managed using the care process model for well-appearing febrile infants and with respiratory viral testing by PCR (RVPCR) in the emergency department or inpatient setting of 22 hospitals in the Intermountain Healthcare system from 2007-2016 were identified. Relative risk (RR) of bacterial infection was calculated for infants with HRV, non-HRV viruses, or no virus detected.
Results:
Of 10 964 febrile infants identified, 4037 (37%) had RVPCR. Of these, 2212 (55%) were positive for a respiratory virus; 1392 (35%) for HRV alone. Bacterial infection was identified in 9.5%. Febrile infants with HRV detected were more likely to have bacterial infection than those with non-HRV viruses (7.8% vs 3.7%; P < .001; RR 2.12 [95% CI 1.43-3.15]). Risk of urinary tract infection was not significantly different for HRV-positive infants at any age, nor was risk of invasive bacterial infection (IBI; bacteremia and/or meningitis) meaningfully different for infants 1-28 day olds. Infants 29-90 days old with HRV had a decreased likelihood of IBI (RR 0.52 [95% CI 0.34-0.80]).
Conclusions:
HRV is common in febrile infants. Detection did not alter risk of concomitant urinary tract infection at any age or risk of IBI in infants 1-28 days old. HRV detection may be relevant in considering risk of IBI for infants 29-90 days of age.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Relative Risk
Drug Dosing: Infants and Children
Drug Toxicity: Risk factors
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Bacterial Signaling

